Docteur BRUNO FAUTREL
✨ Profil synthétique
IA · 04/05/2026Le Docteur Bruno Fautrel est un rhumatologue hospitalier à Paris, avec une activité de recherche importante dans le domaine des maladies auto-immunes et inflammatoires. Il a dirigé plusieurs thèses et a publié de nombreux articles scientifiques, notamment sur l'arthrite rhumatoïde et la spondylarthrite. Son h-index élevé reflète son impact significatif dans la communauté scientifique.
Expertises présumées
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Arthrite juvénile
- Lombalgie
- Thérapies anti-TNF
- Biothérapies non-anti-TNF
- JAK inhibiteurs
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Direction de thèses
🎓 2 thèses dirigéesLa prise en charge de l'arthrose des membres inférieurs ; aspect de santé publique
2019Doctorant·e : Jean-Hugues Salmon
Médecine🎓 ReimsLes utilités EQ-5D et SF-6D dans la polyarthrite débutante
2012Doctorant·e : Cécile Gaujoux-Viala
Sciences de la Vie et de la Santé🎓 Université de Lorraine
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
71
h articles cités ≥ h fois chacun. Un h de 71 = 71 publications avec 71+ citations.
Citations
19 454
Publications
906
i10-index
269
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×506
- Spondyloarthritis Studies and Treatments ×224
- Autoimmune and Inflammatory Disorders Research ×172
- Systemic Lupus Erythematosus Research ×82
- Biosimilars and Bioanalytical Methods ×63
Affiliations FR : Inserm · Université Sorbonne Nouvelle · Université Paris Cité
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: a population-based cohort study
2026ArticleJoint Bone Spine
Association between rheumatoid arthritis flares and joint structural changes at 24 months: using FLARE-RA questionnaire
2026ArticleJoint Bone Spine
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
2025ArticleThe Lancet Rheumatology
Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid‐Dependent Polymyalgia Rheumatica
2025ArticleArthritis & rheumatology
Biopsychosocial phenotyping of patients with chronic low back pain using the pain and disability drivers management model: A retrospective cohort study
2025ArticleJournal of Back and Musculoskeletal Rehabilitation
Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service
2025ArticleRheumatology
Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
2025ArticleRMD Open
Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: Reply
2025ArticleRheumatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
GHU APHP SUN SITE PITIE SALPETRIERE
47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement
☎ 0142160000Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal22
▼
Transversal22
▼- Adult patients with autoinflammation of unknown origin partially phenocopy the immune presentation of Still's disease
Nature communications · 2026 · Journal Article
Veiga R, De Vuyst L, Poulet C, Neumann J, et al.
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
Annals of the rheumatic diseases · 2026 · Journal Article
Smolen JS, Edwards CJ, Konzett V, Laskou F, et al.
- Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung disease
Joint bone spine · 2026 · Journal Article
Juge PA, Debray MP, Pensec VD, Richez C, et al.
- Health care practices in symptomatic knee and hip osteoarthritis patients: The KHOALA cohort
Joint bone spine · 2026 · Journal Article
Rat AC, Salmon JH, Ngueyon Sime W, Saraux A, et al.
- Association between rheumatoid arthritis flares and joint structural changes at 24 months: using FLARE-RA questionnaire
Joint bone spine · 2026 · Journal Article
Fautrel B, Bialé L, Couderc M, Basch A, et al.
🩺 Clinique - Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France
Joint bone spine · 2025 · Journal Article
Molto A, Arnaud L, Chartier M, Panes A, et al.
📚 1 cit. - Response to correspondence on 'Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15' by Boucly A, et al
Annals of the rheumatic diseases · 2025 · Letter
Mitrovic S, Boucly A, Sitbon O, Fautrel B, et al.
- Exposure during pregnancy to Il-1 targeted therapies and pregnancy, foetal and neonatal outcomes: a study from the French Teratology Information Service
Rheumatology (Oxford, England) · 2025 · Journal Article
Faure-Bardon V, Beghin D, Fautrel B, Latour M, et al.
📚 1 cit.🩺 Clinique - Response to correspondence on: Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
Annals of the rheumatic diseases · 2025 · Letter
Mitrovic S, Boucly A, Sitbon O, Fautrel B, et al.
📚 1 cit. - Association between weather features and symptoms in hand osteoarthritis: Results from the DIGICOD cohort
Osteoarthritis and cartilage open · 2025 · Journal Article
Pezot M, Lacoste-Badie R, Tuffet S, Rousseau A, et al.
- Greater pain and functional impairment in chronic erosive hand osteoarthritis compared to treated rheumatoid arthritis: A comparative study
Osteoarthritis and cartilage open · 2025 · Journal Article
Berkani S, Tuffet S, Rousseau A, Rincheval N, et al.
- Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15
Annals of the rheumatic diseases · 2025 · Journal Article
Boucly A, Mitrovic S, Carmagnat M, Savale L, et al.
📚 9 cit.🎯 RCR 3.69 - Adaptive immune responses to SARS-CoV-2 in DMARD-treated patients with chronic inflammatory rheumatisms
RMD open · 2025 · Journal Article
Beretta M, Martin E, Fogel O, López-Medina C, et al.
- The use of IL-1 and IL-6 inhibitors should be prioritised in Still's disease
The Lancet. Rheumatology · 2025 · Letter
Mitrovic S, Sinha R, De Benedetti F, Fautrel B
- Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies
RMD open · 2025 · Journal Article
Robert M, Nguyen Y, Allenbach Y, Sacre K, et al.
- Serum interleukin-18 levels are specifically elevated in auto-inflammatory diseases involving the pyrin inflammasome: A study on 516 patients
European journal of internal medicine · 2025 · Journal Article
Elhani I, Calas L, Bejar F, Fautrel B, et al.
📚 8 cit.🎯 RCR 3.36 - Global health in axial spondyloarthritis: thresholds for the Assessment of SpondyloArthritis international Society Health Index and the EuroQol score: analysis of the ASAS-PerSpA study
Scandinavian journal of rheumatology · 2025 · Journal Article
Drouet J, López-Medina C, Molto A, Granger B, et al.
- Metabolic syndrome is associated with more pain in hand osteoarthritis: Results from the DIGICOD cohort
Osteoarthritis and cartilage open · 2025 · Journal Article
Charton A, Lacoste-Badie R, Tuffet S, Rousseau A, et al.
📚 6 cit.🎯 RCR 2.70 - Factors associated with dietary practices and beliefs on food of patients with rheumatic and musculoskeletal diseases: A multicentre cross-sectional study
Joint bone spine · 2025 · Journal Article
Renard D, Tuffet S, Dieudé P, Claudepierre P, et al.
📚 7 cit.🎯 RCR 3.09 - 2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis
Joint bone spine · 2024 · Journal Article
Fautrel B, Kedra J, Rempenault C, Juge PA, et al.
📚 10 cit.🎯 RCR 2.84🔬→🩺 Translationnel - Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
Clinical and experimental rheumatology · 2024 · Journal Article
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, et al.
- The Flare-OA-16 questionnaire measuring flare in knee and hip osteoarthritis in the patient perspective: scale reduction and validation using a Rasch model
Journal of clinical epidemiology · 2024 · Journal Article
Queiroga F, Epstein J, Erpelding ML, Spitz E, et al.
📚 3 cit.🎯 RCR 1.43
Anti-TNF5
▼
Anti-TNF5
▼- Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
RMD open · 2026 · Journal Article
Taylor PC, Kavanaugh A, Bessette L, Fautrel B, et al.
🩺 Clinique - Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
Advances in therapy · 2025 · Journal Article
Marotte H, Cantagrel A, Coury F, Schaeverbeke T, et al.
📚 2 cit.🩺 Clinique - Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology (Oxford, England) · 2025 · Journal Article
Nguyen Y, Baron G, Hamamouche N, Belkhir R, et al.
📚 1 cit.🩺 Clinique - Correction: Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Drugs - real world outcomes · 2025 · Published Erratum
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, et al.
- Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the PERFUSE Study
Drugs - real world outcomes · 2024 · Journal Article
Fautrel B, Bouhnik Y, Salliot C, Carbonnel F, et al.
📚 2 cit.
Arthrite juvénile4
▼
Arthrite juvénile4
▼- French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's disease
La Revue de medecine interne · 2025 · Journal Article
Quartier P, Belot A, Breton S, Carbasse A, et al.
📚 1 cit.🩺 Clinique - Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease and should now be designated by the same unique name, Still's disease
Joint bone spine · 2025 · Editorial
Mitrovic S, Fautrel B
📚 2 cit. - EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
Annals of the rheumatic diseases · 2024 · Consensus Statement
Fautrel B, Mitrovic S, De Matteis A, Bindoli S, et al.
📚 114 cit.🎯 RCR 29.86🩺 Clinique - Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease
Annals of the rheumatic diseases · 2024 · Journal Article
De Matteis A, Bindoli S, De Benedetti F, Carmona L, et al.
📚 35 cit.🎯 RCR 8.70🔬→🩺 Translationnel
Épidémiologie & registres4
▼
Épidémiologie & registres4
▼- Development and validation of clinical criteria for the definition of disease activity in adult-onset Still's disease: a cohort study
The Lancet. Rheumatology · 2026 · Journal Article
Ruscitti P, Stamm T, Ritschl V, Mitrovic S, et al.
📚 1 cit. - AA amyloidosis in inflammatory joint diseases in the era of biological therapies: Prevalence, manifestations, management and evolution
Joint bone spine · 2026 · Journal Article
Raymond A, Savadogo B, Bourguiba R, Dellal A, et al.
- Social and occupational factors are associated with musculoskeletal pain prevalence in the general population: A population-based cohort study
Joint bone spine · 2026 · Journal Article
Bailly F, Granger B, Foltz V, Kab S, et al.
- Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study
Joint bone spine · 2025 · Journal Article
Le Joncour A, Charuel JL, Choquet S, Spano JP, et al.
📚 1 cit.
Biothérapies non-anti-TNF3
▼
Biothérapies non-anti-TNF3
▼- Maintenance of Remission After Tocilizumab Withdrawal in Patients With Glucocorticoid-Dependent Polymyalgia Rheumatica
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Chevet B, Souki A, Nowak E, Carvajal-Alegria G, et al.
📚 1 cit.🩺 Clinique - Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old
Frontiers in medicine · 2025 · Journal Article
Fautrel B, Saraux A, Idier I, Combe B
- Abatacept versus tocilizumab for the treatment of rheumatoid arthritis in TNF inhibitor inadequate responders: study protocol of the SUNSTAR randomised controlled open-label superiority trial
BMJ open · 2025 · Clinical Trial Protocol
Pascart T, Fautrel B, Gottenberg JE, Ducoulombier V, et al.
🩺 Clinique
JAK inhibiteurs3
▼
JAK inhibiteurs3
▼- Impact of regulatory events on JAK inhibitor prescribing in rheumatoid arthritis: Insights from the French MAJIK Registry
Joint bone spine · 2026 · Letter
Truchetet ME, Prati C, Thevenot P, Bologna C, et al.
- Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients
Rheumatology and therapy · 2026 · Published Erratum
Alten R, Burmester GR, Matucci-Cerinic M, Salmon JH, et al.
- Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
RMD open · 2026 · Journal Article
Taylor PC, Kavanaugh A, Bessette L, Fautrel B, et al.
🩺 Clinique
Lombalgie2
▼
Lombalgie2
▼- Biopsychosocial phenotyping of patients with chronic low back pain using the pain and disability drivers management model: A retrospective cohort study
Journal of back and musculoskeletal rehabilitation · 2026 · Journal Article
Le Cam S, Artico R, Yameogo WN, Tousignant-Laflamme Y, et al.
- Predictors of return to work after multidisciplinary rehabilitation program for patients with chronic low back pain
Joint bone spine · 2025 · Journal Article
Le Cam S, Foltz V, Fautrel B, Bailly F
📚 2 cit.
Revue / méta-analyse2
▼
Revue / méta-analyse2
▼- AA amyloidosis in inflammatory joint diseases: A systematic review
Seminars in arthritis and rheumatism · 2025 · Journal Article
Savadogo B, Fahed H, Sellam J, Georgin-Lavialle S, et al.
📚 2 cit. - Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
Annals of the rheumatic diseases · 2024 · Journal Article
Bindoli S, De Matteis A, Mitrovic S, Fautrel B, et al.
📚 32 cit.🎯 RCR 7.22🔬→🩺 Translationnel
Revue générale2
▼
Revue générale2
▼- AA amyloidosis in inflammatory joint diseases: A systematic review
Seminars in arthritis and rheumatism · 2025 · Journal Article
Savadogo B, Fahed H, Sellam J, Georgin-Lavialle S, et al.
📚 2 cit. - Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
Annals of the rheumatic diseases · 2024 · Journal Article
Bindoli S, De Matteis A, Mitrovic S, Fautrel B, et al.
📚 32 cit.🎯 RCR 7.22🔬→🩺 Translationnel
Spondyloarthrite2
▼
Spondyloarthrite2
▼- Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis
Rheumatology (Oxford, England) · 2025 · Journal Article
Bibas N, Pignon C, Lopez-Medina C, Gandjbakhch F, et al.
📚 8 cit.🎯 RCR 3.74🔬→🩺 Translationnel - Clinical enthesitis in patient with psoriatic arthritis, a systematic literature review with metaanalysis
Joint bone spine · 2025 · Journal Article
Pignon C, Bibas N, Lopez-Medina C, Fautrel B, et al.
📚 4 cit.🔬→🩺 Translationnel
csDMARDs1
▼
csDMARDs1
▼- Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial
The Lancet. Rheumatology · 2025 · Journal Article
Morel J, Dernis E, Roux C, Richez C, et al.
📚 2 cit.🩺 Clinique
Fièvres auto-inflammatoires1
▼
Fièvres auto-inflammatoires1
▼- A Multifaceted Interplay Among Hemophagocytosis, Interleukin-18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases
Arthritis & rheumatology (Hoboken, N.J.) · 2026 · Journal Article
Mueller YM, Girard C, van de Werken HJG, Erkeland SJ, et al.
Génétique1
▼
Génétique1
▼- Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's Disease
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Topping J, Chang L, Nadat F, Poulter JA, et al.
📚 6 cit.🎯 RCR 2.43
Pharmacovigilance1
▼
Pharmacovigilance1
▼- Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
Annals of the rheumatic diseases · 2024 · Journal Article
Bindoli S, De Matteis A, Mitrovic S, Fautrel B, et al.
📚 32 cit.🎯 RCR 7.22🔬→🩺 Translationnel
Qualité de vie / PROMs1
▼
Qualité de vie / PROMs1
▼- Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
Rheumatology and therapy · 2025 · Journal Article
Taylor PC, Fakhouri W, Ogwu S, Haladyj E, et al.
📚 5 cit.🎯 RCR 2.25
Datasets & protocoles partagés
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Collection2017FigshareAbstract Background Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patien
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Collection2017FigshareAbstract Background Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patien
Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain
Collection2019FigshareAbstract Introduction Health-related quality of life (HRQoL) is a priority for patients. The objectives were to describe the changes in HRQoL over 5–8 years in patients with early arthritis (EA) or early inflammatory bac
Similar alteration for mental and physical aspects in health-related quality of life over 5 to 8 years in 1347 patients with early arthritis and early inflammatory back pain
Collection2019FigshareAbstract Introduction Health-related quality of life (HRQoL) is a priority for patients. The objectives were to describe the changes in HRQoL over 5–8 years in patients with early arthritis (EA) or early inflammatory bac
Elicitation of Rheumatologist Preferences for the Treatment of Patients with Rheumatoid Arthritis After the Failure of a First Conventional Synthetic Disease-Modifying Anti-Rheumatic Agent
Audiovisual2021Adis Journals<strong>Article full text</strong> <br> The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).